Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$7.67
Day's range
$8.08

Eupraxia Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BEUTEL, GOODMAN & CO LTD. 08/12/2026 3.63 M $23.81 M   -1.05% 5.48%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 1.65 M $10.91 M   3.84% 2.49%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 1.35 M $8.92 M   0.00% 2.04%
VIVO CAPITAL, LLC 08/14/2026 1.35 M $8.92 M   0.00% 2.04%
SCOTIA CAPITAL INC. 08/11/2026 1.34 M $8.78 M   0.12% 2.03%
PFM HEALTH SCIENCES, LP 08/14/2026 1.21 M $8.00 M   123.84% 1.83%
GREAT POINT PARTNERS LLC 08/14/2026 1.20 M $7.93 M   0.00% 1.81%
JUPITER TOPCO LLC 08/14/2026 1.05 M $6.85 M   100.00% 1.58%
RUBRIC CAPITAL MANAGEMENT LP 08/14/2026 867.42 K $5.73 M   25.50% 1.31%
IKARIAN CAPITAL, LLC 08/14/2026 809.74 K $5.35 M   -33.34% 1.22%
WOODLINE PARTNERS LP 08/14/2026 746.86 K $4.94 M   69.53% 1.13%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 730.28 K $4.83 M   -24.52% 1.10%
AMERIPRISE FINANCIAL INC 08/14/2026 711.02 K $4.70 M   9.54% 1.07%
REDMILE GROUP, LLC 08/14/2026 611.40 K $4.04 M   -12.66% 0.92%
SEVEN FLEET CAPITAL MANAGEMENT LP 08/17/2026 610.79 K $4.04 M   40.89% 0.92%
UBS GROUP AG 08/13/2026 519.21 K $3.43 M   -31.92% 0.78%
CITADEL ADVISORS LLC 09/02/2026 502.01 K $3.32 M   118.10% 0.76%
MILLENNIUM MANAGEMENT LLC 08/14/2026 441.59 K $2.92 M   100.00% 0.67%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 375.00 K $2.48 M   0.00% 0.57%
PICTON MAHONEY ASSET MANAGEMENT 08/13/2026 360.88 K $2.39 M   100.00% 0.55%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 08/14/2026 352.00 K $2.33 M   0.00% 0.53%
JANE STREET GROUP, LLC 08/14/2026 329.05 K $2.16 M   834.54% 0.50%
AISLING CAPITAL MANAGEMENT LP 08/13/2026 325.00 K $2.15 M   0.00% 0.49%
SUMMITTX CAPITAL, L.P. 08/14/2026 318.78 K $2.11 M   -2.81% 0.48%
ROYAL BANK OF CANADA 08/14/2026 311.44 K $2.06 M   19.15% 0.47%
DV EQUITIES, LLC 08/14/2026 276.00 K $1.82 M   100.00% 0.42%
ORBIMED ADVISORS LLC 08/14/2026 269.00 K $1.78 M   100.00% 0.41%
BANK OF AMERICA CORP /DE/ 08/14/2026 264.72 K $1.75 M   -1.30% 0.40%
ALLY BRIDGE GROUP (NY) LLC 08/14/2026 252.18 K $1.67 M   -61.81% 0.38%
CIBC WORLD MARKET INC. 08/13/2026 234.67 K $1.54 M   55.46% 0.35%
DAFNA CAPITAL MANAGEMENT LLC 08/14/2026 225.60 K $1.49 M   100.00% 0.34%
TWO SIGMA INVESTMENTS, LP 08/14/2026 221.08 K $1.46 M   1,947.07% 0.33%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 212.65 K $1.41 M   -34.33% 0.32%
MARSHALL WACE, LLP 08/13/2026 158.13 K $1.05 M   0.00% 0.24%
DELANEY CAPITAL MANAGEMENT LTD. 08/14/2026 117.20 K $767.86 K   -1.84% 0.18%
TD WATERHOUSE CANADA INC. 07/27/2026 79.61 K $534.92 K   -2.59% 0.12%
XTX TOPCO LTD 08/14/2026 70.27 K $464.45 K   100.00% 0.11%
INGALLS & SNYDER LLC 08/14/2026 68.45 K $452.00 K   -9.52% 0.10%
ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC 08/10/2026 60.00 K $396.60 K   100.00% 0.09%
GOLDMAN SACHS GROUP INC 08/14/2026 58.06 K $383.76 K   9.38% 0.09%
RAYMOND JAMES FINANCIAL INC 08/14/2026 53.50 K $353.66 K   5.82% 0.08%
1832 ASSET MANAGEMENT L.P. 08/13/2026 50.43 K $333.36 K   -15.95% 0.08%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 46.15 K $305.02 K   617.76% 0.07%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 43.49 K $287.48 K   100.00% 0.07%
BANK OF MONTREAL /CAN/ 08/12/2026 38.46 K $252.20 K   0.54% 0.06%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 36.21 K $239.35 K   41.38% 0.05%
BREVAN HOWARD CAPITAL MANAGEMENT LP 08/14/2026 34.77 K $229.81 K   100.00% 0.05%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 34.24 K $226.31 K   100.00% 0.05%
TORONTO DOMINION BANK 08/14/2026 30.92 K $202.77 K   -6.01% 0.05%
AXQ CAPITAL, LP 08/06/2026 21.15 K $139.80 K   34.20% 0.03%

Eupraxia Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 73 institutional investors and hedge funds held shares of Eupraxia Pharmaceuticals Inc. The most heavily invested institutionals were:

Beutel, Goodman & Co Ltd.: 3.63 M

Affinity Asset Advisors, LLC: 1.65 M

BALYASNY ASSET MANAGEMENT L.P.: 1.35 M

Vivo Capital, LLC: 1.35 M

SCOTIA CAPITAL INC.: 1.34 M

PFM Health Sciences, LP: 1.21 M

37.47% of Eupraxia Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 24.81 M shares in the last 24 months. This purchase volume represents approximately $194.02 M in transactions.